Account
Insider Insights
01.02.2022
NICE changes to its methods and processes

The changes cover how topics are chosen, the steps and stages in each evaluation and how evidence is...

Read more
Publications
03.12.2021
Pricing and reimbursement policies for digital the

Digital therapeutics (DTx) is a category of digital health, which is defined as products that delive...

Read more
News
15.09.2021
PMA Insight: Week 37 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
23.08.2021
Indirect treatment comparisons guide

ITC can provide an estimate of the relative treatment effect of two products that have not been comp...

Read more
Articles
05.08.2021
DTx Trends in EU5

The unprecedented growth of the Digital Therapeutic Market (DTx) has been one of the key highlights ...

Read more
News
23.06.2021
PMA Insights: Week 25

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
News
11.03.2021
Asia Pacific Digital Health Insights

Remap Consulting recently attended an ISPOR webinar discussing the digital health ecosystem in APAC ...

Read more
Articles
02.06.2020
Artificial intelligence in market access

AI technologies are becoming increasingly relevant in many fields, such as business and marketing an...

Read more
Articles
27.03.2020
NICE postpones technology appraisals

NICE confirmed that they will be prioritising work that is therapeutically critical or relates to ad...

Read more
Articles
18.05.2015
Biosimilar pricing and reimbursement pathways

European payers have not considered biosimilars to be comparable to their reference products or full...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.